I'm an adult with type 2 diabetes (T2D), hypertension (HTN), hyperlipidemia, and impaired renal function, and I recently started taking a GLP-1 (Glucagon-like peptide-1) receptor agonist injection, possibly liraglutide (Victoza) or semaglutide (Ozempic), and I'm experiencing pain in my right rib area, what could be causing this pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Right Rib Area Pain After Starting GLP-1 Injection

The pain in your right rib area is most likely unrelated to the GLP-1 injection itself and warrants evaluation for other causes, particularly musculoskeletal conditions like painful rib syndrome or gastrointestinal issues related to your existing conditions.

Understanding GLP-1 Side Effects

GLP-1 receptor agonists like liraglutide and semaglutide primarily cause gastrointestinal adverse effects that affect the upper GI tract through delayed gastric emptying, reduced gastric acid secretion, and increased gastric volumes 1. The most common side effects include:

  • Nausea, vomiting, and diarrhea are dose-dependent and occur more frequently with short-acting formulations 2, 3
  • Constipation is a significant risk, particularly with semaglutide (risk ratio 6.17) 1, 4
  • Most GI adverse events occur within the first month of therapy and may improve with continued use due to tachyphylaxis 1
  • These effects are transient and tend to occur during dose escalation 2

Why Right Rib Pain is Unlikely from GLP-1

GLP-1 medications do not have a recognized mechanism for causing localized rib pain. The medication works systemically on the GI tract and does not cause direct musculoskeletal or localized pain 1. The location of your pain (right rib area) suggests alternative explanations:

Alternative Causes to Consider

Painful rib syndrome is a common condition accounting for 3% of new referrals to gastroenterology clinics, characterized by:

  • Pain in the lower chest or upper abdomen
  • A tender spot on the costal margin
  • Reproduction of pain when pressing the tender spot
  • More common in women (70% of cases) 5

Other considerations with your medical profile:

  • Gastrointestinal issues related to your existing conditions (T2D, HTN, hyperlipidemia)
  • Musculoskeletal strain or costochondritis
  • Gallbladder issues (though 8 patients in one study had non-curative cholecystectomies for this syndrome) 5

What You Should Do

Systematic firm palpation of the costal margin is recommended to identify a tender spot characteristic of painful rib syndrome 5. If pressing on a specific point on your rib margin reproduces your pain, this is likely the diagnosis and requires no investigation 5.

Regarding Your GLP-1 Medication

You should continue your GLP-1 receptor agonist unless you develop severe gastrointestinal symptoms 2. The medication provides important benefits for your diabetes, cardiovascular risk, and renal function 2:

  • Cardiovascular benefits: Liraglutide and semaglutide reduce cardiovascular events in patients with T2D and high cardiovascular risk 2, 6
  • Renal protection: GLP-1 receptor agonists are associated with lower risk of renal endpoints when eGFR is >30 mL/min/1.73m² 2
  • Metabolic benefits: Weight loss, blood pressure reduction, and improved glycemic control 2, 7

When to Seek Immediate Evaluation

Contact your healthcare provider if you develop:

  • Severe, persistent abdominal pain that could indicate pancreatitis (use GLP-1 receptor agonists with caution if you have a history of pancreatitis) 3
  • Signs of bowel obstruction (severe constipation, inability to pass gas, vomiting) 4
  • Worsening pain or new symptoms

Common Pitfalls to Avoid

  • Do not discontinue GLP-1 therapy prematurely for mild gastrointestinal symptoms, as most are manageable with supportive care 1, 4
  • Do not attribute all new symptoms to the newest medication without considering other common causes 5
  • Ensure slow dose titration to minimize gastrointestinal side effects if you're just starting therapy 2, 4

Given your impaired renal function, note that renal dysfunction does not increase liraglutide exposure, and no dose adjustment is required 8.

References

Guideline

GLP-1 Receptor Agonists and Gastrointestinal Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

GLP-1 Receptor Agonists in Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Managing Constipation in Patients Taking GLP-1 Receptor Agonists

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Liraglutide: a new treatment for type 2 diabetes.

Drugs of today (Barcelona, Spain : 1998), 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.